-+ 0.00%
-+ 0.00%
-+ 0.00%

BRISTOL-MYERS SQUIBB COMPANY - ARLO-CEL SHOWS SIGNIFICANT OVERALL RESPONSE RATE IN PATIENTS WITH FOUR OR MORE PRIOR THERAPIES

Reuters·09/08/2026 10:59:00

Please log in to view news